Paper33918878
Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions.
Notarnicola M and 14 others. Int J Mol Sci, 2021. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions. Papers, record 33918878. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33918878
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers | Major topic |
| Disease Susceptibility | Major topic |
| Non-alcoholic Fatty Liver Disease | Major topic |
| Animals | |
| Cytokines | |
| Diet | |
| Disease Management | |
| Exercise | |
| Exosomes | |
| Fatty Acids | |
| Health Behavior | |
| Hepatocytes | |
| Humans | |
| Life Style | |
| Lipid Metabolism | |
| Lipidomics | |
| Lipids | |
| Microbiota |
Source PubMed
References147
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26406121 | Mixed lineage kinase 3 mediates release of C-X-C motif ligand 10-bearing chemotactic extracellular vesicles from lipotoxic hepatocytes. | Hepatology | 2016 | https://conductscience.org/library/papers/26406121 | PubMed |
| 2 | 20105293 | A rapid method for determining arachidonic:eicosapentaenoic acid ratios in whole blood lipids: correlation with erythrocyte membrane ratios and validation in a large Italian population of various ages and pathologies. | Lipids Health Dis | 2010 | https://conductscience.org/library/papers/20105293 | PubMed |
| 3 | 30502373 | Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. | Metabolism | 2019 | https://conductscience.org/library/papers/30502373 | PubMed |
| 4 | 26950145 | An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity. | Nutrients | 2016 | https://conductscience.org/library/papers/26950145 | PubMed |
| 5 | 31389294 | Non-alcoholic fatty liver disease (NAFLD) is associated with dynamic changes in DNA hydroxymethylation. | Epigenetics | 2020 | https://conductscience.org/library/papers/31389294 | PubMed |
| 6 | 27986466 | Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies. | Trends Endocrinol Metab | 2017 | https://conductscience.org/library/papers/27986466 | PubMed |
| 7 | 19769633 | Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease. | Aliment Pharmacol Ther | 2009 | https://conductscience.org/library/papers/19769633 | PubMed |
| 8 | 29572551 | Lack of evidence supporting a role of TMC4-rs641738 missense variant-MBOAT7- intergenic downstream variant-in the Susceptibility to Nonalcoholic Fatty Liver Disease. | Sci Rep | 2018 | https://conductscience.org/library/papers/29572551 | PubMed |
| 9 | 32298765 | Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆. | J Hepatol | 2020 | https://conductscience.org/library/papers/32298765 | PubMed |
| 10 | 32714204 | Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases. | Front Physiol | 2020 | https://conductscience.org/library/papers/32714204 | PubMed |
| 11 | 26462489 | Poor Inter-test Reliability Between CK18 Kits as a Biomarker of NASH. | Dig Dis Sci | 2016 | https://conductscience.org/library/papers/26462489 | PubMed |
| 13 | 25955209 | Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. | Cell Metab | 2015 | https://conductscience.org/library/papers/25955209 | PubMed |
| 14 | 29122391 | Genetics and epigenetics of NAFLD and NASH: Clinical impact. | J Hepatol | 2018 | https://conductscience.org/library/papers/29122391 | PubMed |
| 15 | 30345152 | Extracellular vesicles in non-alcoholic and alcoholic fatty liver diseases. | Liver Res | 2018 | https://conductscience.org/library/papers/30345152 | PubMed |
| 16 | 33217052 | A review of non-alcoholic fatty liver disease in non-obese and lean individuals. | J Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/33217052 | PubMed |
| 17 | 31726714 | Effects of Some Food Components on Non-Alcoholic Fatty Liver Disease Severity: Results from a Cross-Sectional Study. | Nutrients | 2019 | https://conductscience.org/library/papers/31726714 | PubMed |
| 18 | 11054393 | Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. | Gastroenterology | 2000 | https://conductscience.org/library/papers/11054393 | PubMed |
| 19 | 26985892 | Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/26985892 | PubMed |
| 20 | 25744849 | Amphiregulin activates human hepatic stellate cells and is upregulated in non alcoholic steatohepatitis. | Sci Rep | 2015 | https://conductscience.org/library/papers/25744849 | PubMed |
| 21 | 31027294 | Elevated AA/EPA Ratio Represents an Inflammatory Biomarker in Tumor Tissue of Metastatic Colorectal Cancer Patients. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31027294 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41909260 | Paeoniflorin protects against NAFLD through antioxidant, anti-inflammatory effects and restoration of gut microbiota homeostasis. | Front Microbiol | 2026 | https://conductscience.org/library/papers/41909260 | PubMed |
| 41782035 | Integrated lifestyle management to mitigate MASLD risk in patients with chronic kidney disease: a prospective cohort study. | J Transl Med | 2026 | https://conductscience.org/library/papers/41782035 | PubMed |
| 40331190 | Targeting fibroblast growth factor (FGF)-21: a promising strategy for metabolic dysfunction-associated steatotic liver disease treatment. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40331190 | PubMed |
| 40074255 | Association of occupational noise exposure and shift work with non-alcoholic fatty liver disease: a cross-sectional study of male workers in the Chinese automobile manufacturing industry. | BMJ Open | 2025 | https://conductscience.org/library/papers/40074255 | PubMed |
| 38541057 | Significant Increase in Oxidative Stress Indices in Erythrocyte Membranes of Obese Patients with Metabolically-Associated Fatty Liver Disease. | J Pers Med | 2024 | https://conductscience.org/library/papers/38541057 | PubMed |
| 38448563 | Optimizing lifestyle profiles is potential for preventing nonalcoholic fatty liver disease and enhancing its survival. | Sci Rep | 2024 | https://conductscience.org/library/papers/38448563 | PubMed |
| 37892698 | Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium-Glucose Cotransporter 2 Inhibitor Therapy. | J Clin Med | 2023 | https://conductscience.org/library/papers/37892698 | PubMed |
| 37056283 | Assessing the causal relationships between human blood metabolites and the risk of NAFLD: A comprehensive mendelian randomization study. | Front Genet | 2023 | https://conductscience.org/library/papers/37056283 | PubMed |
| 36675254 | Plasma-Derived Exosomes from NAFLD Patients Modulate the Cannabinoid Receptors' Expression in Cultured HepaRG Cells. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36675254 | PubMed |
| 36425787 | Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/36425787 | PubMed |
| 36358589 | Role of Oxidative Stress and Lipid Peroxidation in the Pathophysiology of NAFLD. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/36358589 | PubMed |
| 35334792 | Exosomal FZD-7 Expression Is Modulated by Different Lifestyle Interventions in Patients with NAFLD. | Nutrients | 2022 | https://conductscience.org/library/papers/35334792 | PubMed |
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33918878
GET https://conductscience.org/api/papers/v1/33918878/references?page=2